May 28, 2019

U.S. In-Vitro Diagnostic Substances Market. Analysis And Forecast to 2025

Licenses

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service and Privacy Policy. We'll occasionally send you account related emails.

U.S.: In-Vitro Diagnostic Substance Market Overview 2019

In-Vitro Diagnostic Substance Market Size in the USA

The revenue of the in-vitro diagnostic substance market in the U.S. amounted to $X in 2018, remaining constant against the previous year. Overall, in-vitro diagnostic substance consumption continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2015, with an increase of X% against the previous year. Over the period under review, the in-vitro diagnostic substance market reached its maximum level of $X in 2013; however, from 2014 to 2018, it stood at a somewhat lower level.

In-Vitro Diagnostic Substance Production in the USA

In value terms, in-vitro diagnostic substance production stood at $X in 2018. Overall, in-vitro diagnostic substance production continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2015, when the output figure increased by X% against the previous year. Over the period under review, the in-vitro diagnostic substance production attained its peak figure level of $X in 2013; however, from 2014 to 2018, it stood at a somewhat lower level.

In-Vitro Diagnostic Substance Exports

Exports from the USA

In 2018, approx. X tonnes of in-vitro diagnostic substances were exported from the U.S.; lowering by -X% against the previous year. The total export volume increased an average annual rate of +X% over the period from 2013 to 2018; the trend pattern remained relatively stable, with somewhat noticeable fluctuations being observed over the period under review. The pace of growth was the most pronounced in 2014, when exports increased by X% year-to-year. Over the period under review, the in-vitro diagnostic substance exports attained its maximum volume of X tonnes in 2015; however, from 2016 to 2018, it failed to regain its momentum.

In value terms, in-vitro diagnostic substance exports stood at $X in 2018. The total export value increased an average annual rate of +X% over the period from 2013 to 2018; the trend pattern remained consistent, with somewhat noticeable fluctuations being recorded in certain years. In that year, the in-vitro diagnostic substance exports reached their peak level, and are likely to continue its growth in the immediate term.

Exports by Country

Belgium (X tonnes), China (X tonnes) and France (X tonnes) were the main destinations of in-vitro diagnostic substance exports from the U.S., together accounting for X% of total exports. These countries were followed by the UK, South Korea, Japan, Singapore, the Netherlands, Brazil and Spain, which together accounted for a further X%.

From 2013 to 2018, the most notable rate of growth in terms of exports, amongst the main countries of destination, was attained by Spain (+X% per year), while the other leaders experienced more modest paces of growth.

In value terms, largest markets for in-vitro diagnostic substance exported from the U.S. were Belgium ($X), the Netherlands ($X) and the UK ($X), with a combined X% share of total exports. Japan, China, South Korea, France, Singapore, Brazil and Spain lagged somewhat behind, together accounting for a further X%.

Spain (+X% per year) experienced the highest rates of growth with regard to exports, in terms of the main countries of destination over the last five year period, while the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2018, the average in-vitro diagnostic substance export price amounted to $X per kg, growing by X% against the previous year. Over the period from 2013 to 2018, it increased at an average annual rate of +X%. The most prominent rate of growth was recorded in 2018, an increase of X% year-to-year. In that year, the average export prices for in-vitro diagnostic substances attained their peak level, and is likely to continue its growth in the immediate term.

Export prices varied noticeably by the country of origin; the country with the highest export price was the Netherlands ($X per kg), while average price for exports to Spain ($X per kg) was amongst the lowest.

From 2013 to 2018, the most notable rate of growth in terms of export prices was recorded for supplies to the Netherlands (+X% per year), the export prices for the other major destinations experienced more modest paces of growth.

In-Vitro Diagnostic Substance Imports

Imports into the USA

In-vitro diagnostic substance imports into the U.S. totaled X tonnes in 2018, surging by X% against the previous year. The total import volume increased an average annual rate of +X% over the period from 2013 to 2018; the trend pattern remained consistent, with only minor fluctuations being observed in certain years. The most prominent rate of growth was recorded in 2017, when it surged by X% against the previous year. Over the period under review, the in-vitro diagnostic substance imports attained its maximum volume in 2018, and are expected to retain its growth in the immediate term.

In value terms, in-vitro diagnostic substance imports totaled $X in 2018. The total import value increased an average annual rate of +X% from 2013 to 2018; the trend pattern indicated some noticeable fluctuations throughout the analyzed period. Over the period under review, the in-vitro diagnostic substance imports attained its peak figure level in 2018, and are likely to see steady growth in the immediate term.

Imports by Country

China (X tonnes), Germany (X tonnes) and Italy (X tonnes) were the main suppliers of in-vitro diagnostic substance imports to the U.S., with a combined X% share of total imports. Norway, Japan, the UK, Hungary, Ireland and Taiwan, Chinese lagged somewhat behind, together accounting for a further X%.

From 2013 to 2018, the most notable rate of growth in terms of imports, amongst the main suppliers, was attained by Norway (+X% per year), while the other leaders experienced more modest paces of growth.

In value terms, largest in-vitro diagnostic substance suppliers to the U.S. were China ($X), the UK ($X) and Germany ($X), with a combined X% share of total imports. These countries were followed by Norway, Japan, Italy, Ireland, Taiwan, Chinese and Hungary, which together accounted for a further X%.

Among the main suppliers, Norway (+X% per year) recorded the highest rates of growth with regard to imports, over the last five years, while the other leaders experienced more modest paces of growth.

Import Prices by Country

The average in-vitro diagnostic substance import price stood at $X per kg in 2018, rising by X% against the previous year. Over the period from 2013 to 2018, it increased at an average annual rate of +X%. The most prominent rate of growth was recorded in 2018, an increase of X% y-o-y. In that year, the average import prices for in-vitro diagnostic substances attained their peak level, and is likely to continue its growth in the immediate term.

There were significant differences in the average import prices amongst the major supplying countries. In 2018, the country with the highest import price was the UK ($X per kg), while price for Hungary ($X per kg) was amongst the lowest.

From 2013 to 2018, the most notable rate of growth in terms of import prices was attained by the UK (+X% per year), the import prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox AI Platform

Product coverage:

In-vitro diagnostic substances


The report provides on a detailed analysis of the U.S. in-vitro diagnostic substance market. It reveals the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the leading players in the industry.


Countries coverage: the U.S.


Companies mentioned:

Abbott Diabetes Care,

Orasure Technologies,

Amag Pharmaceuticals,

Streck, Diasorin Inc.,

Diadexus,

Rapid Pathogen Screening,

Maine Biotechnology Services,

Saladax Biomedical,

Corgenix Medical Corporation,

George King Bio-Medical,

Princeton Biomeditech Corp,

Banyan Biomarkers,

Anatech,

Dxna LLC,

CD Diagnostics,

Akers Biosciences,

Helica Biosystems,

Green Mountain Antibodies,

Biospacific, Innominata,

Phase 2 Discovery,

Immuno Concepts,

Hepatochem,

Lifecare Medical International,

Horizon Diagnostic,

Immucor Gti Diagnostics,

Werfen USA,

Ivd Intermediate Holdings B Inc.,

Opko Diagnostics,

Horizon Diagnostic Inc,

Immucor Gti Diagnostics,

Werfen USA,

Ivd Intermediate Holdings B Inc.,

Opko Diagnostics


Data coverage:

• In-vitro diagnostic substance market size;

• In-vitro diagnostic substance production, value of shipments;

• Key market players and their profiles;

• Exports, imports and trade balance;

• Import and export prices;

• Forecast of the market dynamics in the medium term;

• Key industry statistics;

• Life cycle of the in-vitro diagnostic substance industry;

• Number of establishments and their locations;

• Employment data;

• In-vitro diagnostic substance industry productivity.


Reasons to buy this report:

• Take advantage of the latest data;

• Find deeper insights into current market developments;

• Discover vital success factors affecting the market.


This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.


In this report, you can find information that helps you to make informed decisions on the following issues


1. How to diversify your business and benefit from new market opportunities

2. How to load your idle production capacity

3. How to boost your sales on overseas markets

4. How to increase your profit margins

5. How to make your supply chain more sustainable

6. How to reduce your production and supply chain costs

7. How to outsource production to other countries

8. How to prepare your business for global expansion


While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

2.1
KEY FINDINGS
2.2
MARKET TRENDS
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2025
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2013–2018
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2013–2018
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2018
Table 2:
Market Volume, In Physical Terms, 2013–2018
Table 3:
Market Value, 2013–2018
Table 4:
Per Capita Consumption In 2013–2018
Table 5:
Imports, In Physical Terms, By Country, 2013–2018
Table 6:
Imports, In Value Terms, By Country, 2013–2018
Table 7:
Import Prices, By Country Of Origin, 2013–2018
Table 8:
Exports, In Physical Terms, By Country, 2013–2018
Table 9:
Exports, In Value Terms, By Country, 2013–2018
Table 10:
Export Prices, By Country Of Destination, 2013–2018
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2013–2018
Figure 2:
Market Value, 2013–2018
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2013–2018
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2013–2018
Figure 5:
Trade Balance, In Physical Terms, 2013–2018
Figure 6:
Trade Balance, In Value Terms, 2013–2018
Figure 7:
Per Capita Consumption, 2013–2018
Figure 8:
Market Forecast To 2025
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2013–2018
Figure 21:
Production, In Value Terms, 2013–2018
Figure 22:
Imports, In Physical Terms, 2013–2018
Figure 23:
Imports, In Value Terms, 2013–2018
Figure 24:
Imports, In Physical Terms, By Country, 2018
Figure 25:
Imports, In Physical Terms, By Country, 2013–2018
Figure 26:
Imports, In Value Terms, By Country, 2013–2018
Figure 27:
Import Prices, By Country Of Origin, 2013–2018
Figure 28:
Exports, In Physical Terms, 2013–2018
Figure 29:
Exports, In Value Terms, 2013–2018
Figure 30:
Exports, In Physical Terms, By Country, 2018
Figure 31:
Exports, In Physical Terms, By Country, 2013–2018
Figure 32:
Exports, In Value Terms, By Country, 2013–2018
Figure 33:
Export Prices, By Country Of Destination, 2013–2018
Ready to Get Started?

We can help you conduct market research and write a report using the most reliable data

Ready to Get Started?
We can help you conduct market research and write a report using the most reliable data